通过设计降低免疫原性:降低单克隆抗体免疫原性的方法
Chantal T Harris1, Sivan Cohen2
1Department of BioAnalytical Sciences, Genentech Inc., South San Francisco, CA, 94080-4990, USA.
概括
单克隆抗体 (mAbs) 是重要的治疗药物,但它们的免疫性构成了挑战. 本综述涵盖了在药物开发过程中预测和减少对mAbs的免疫反应的进展.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 药物开发 药物开发
背景情况:
- 单克隆抗体 (mAbs) 是一种高度特定的蛋白质疗法,用于各种疾病.
- 在mAb疗法中的一个重大挑战是免疫性,一种不必要的免疫反应.
- 免疫消毒策略对于保持 mAb 的有效性和安全性至关重要.
研究的目的:
- 审查最近在预测mAb免疫性方面的进展.
- 突出蛋白质工程战略,以减少免疫性.
- 在mAb开发中强调全面的免疫性风险评估.
主要方法:
- 在体内,体外和体内免疫性风险评估的策略.
- 对驱动 mAb 免疫性机制的分析.
- 对蛋白质工程技术的审查,以消除免疫.
主要成果:
- 免疫原性在 in silico 预测模型中的进展.
- 开发新的蛋白质工程方法,以减少T细胞表皮图识别.
- 改善了对mAb结构与免疫性之间的关系的理解.
结论:
- 综合免疫性评估对于安全有效的mAb疗法至关重要.
- 蛋白质工程提供了强大的工具来减轻mAb免疫性.
- 需要继续进行研究,以完善治疗抗体的预测和缓解策略.
相关概念视频
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
Immunoprecipitation
5.5K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.5K


